CHRS CIK: 1512762

Coherus Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.60
FY22:
0.38
FY23:
0.48
FY24:
0.34
FY25:
0.21
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.10
FY23:
0.15
FY24:
0.11
FY25:
0.05
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.68
FY22:
0.48
FY23:
0.63
FY24:
0.45
FY25:
0.26

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.14
FY23:
0.33
FY24:
0.28
FY25:
0.14
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.42
FY22:
0.48
FY23:
0.49
FY24:
0.30
FY25:
0.06
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
−0.14
FY23:
−0.19
FY24:
−0.13
FY25:
0.06
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.68
FY22:
0.48
FY23:
0.63
FY24:
0.45
FY25:
0.26

All amounts in billions USD Data source:SEC EDGAR